Marco Picchioni

Marco Picchioni

Auto-generated profile, based on publicly available information

Marco Picchioni

Department of Forensic and Neurodevelopmental Science, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2009 in Nature
Verified
Journal Article
Closed access
PDF file
†(†Genetic Risk and Outcome in Psychosis (GROUP)
†Genetic Risk and Outcome in Psychosis (GROUP)
HSHreinn Stefansson
Hreinn Stefansson
RORoel A. Ophoff
Roel A. Ophoff
SSStacy Steinberg
Stacy Steinberg
OAOle A. Andreassen
Ole A. Andreassen
DCDavid A. Collier
David A. Collier

9 September 2011 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
EDEmma L. Dempster
Emma L. Dempster
RPRuth Pidsley
Ruth Pidsley
LSLeonard C. Schalkwyk
Leonard C. Schalkwyk
SOSheena Owens
Sheena Owens
AGAnna Georgiades
Anna Georgiades
JMJonathan Mill
Jonathan Mill
Studies of the major psychoses, schizophrenia (SZ) and bipolar disorder (BD), have traditionally focused on genetic and environmental risk factors, although more recent work has highlighted an additional role for epigenetic processes in mediating susceptibility. Since monozygotic (MZ) twins share a common DNA sequence, their study represents an ideal design for investigating the contribution of epigenetic factors to disease etiology. We performed a genome-wide analysis of DNA methylation on peripheral blood DNA samples obtained from a unique sample of MZ twin pairs discordant for major psychosis. Numerous loci demonstrated disease-associated DNA methylation differences between twins discordant for SZ and BD individually, and together as a combined major psychosis group. Pathway analysis of our top loci highlighted a significant enrichment of epigenetic changes in biological networks and pathways directly relevant to psychiatric disorder and neurodevelopment. The top psychosis-associated, differentially methylated region, significantly hypomethylated in affected twins, was located in the promoter of ST6GALNAC1 overlapping a previously reported rare genomic duplication observed in SZ. The mean DNA methylation difference at this locus was 6%, but there was considerable heterogeneity between families, with some twin pairs showing a 20% difference in methylation. We subsequently assessed this region in an independent sample of postmortem brain tissue from affected individuals and controls, finding marked hypomethylation (>25%) in a subset of psychosis patients. Overall, our data provide further evidence to support a role for DNA methylation differences in mediating phenotypic differences between MZ twins and in the etiology of both SZ and BD.

22 October 2008 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
DRDan Rujescu
Dan Rujescu
AIAndres Ingason
Andres Ingason
SCSven Cichon
Sven Cichon
OPOlli P.H. Pietiläinen
Olli P.H. Pietiläinen
MBMichael R. Barnes
Michael R. Barnes
DCDavid A. Collier
David A. Collier
Deletions within the neurexin 1 gene (NRXN1; 2p16.3) are associated with autism and have also been reported in two families with schizophrenia. We examined NRXN1, and the closely related NRXN2 and NRXN3 genes, for copy number variants (CNVs) in 2977 schizophrenia patients and 33 746 controls from seven European populations (Iceland, Finland, Norway, Germany, The Netherlands, Italy and UK) using microarray data. We found 66 deletions and 5 duplications in NRXN1, including a de novo deletion: 12 deletions and 2 duplications occurred in schizophrenia cases (0.47%) compared to 49 and 3 (0.15%) in controls. There was no common breakpoint and the CNVs varied from 18 to 420 kb. No CNVs were found in NRXN2 or NRXN3. We performed a Cochran–Mantel–Haenszel exact test to estimate association between all CNVs and schizophrenia (P = 0.13; OR = 1.73; 95% CI 0.81–3.50). Because the penetrance of NRXN1 CNVs may vary according to the level of functional impact on the gene, we next restricted the association analysis to CNVs that disrupt exons (0.24% of cases and 0.015% of controls). These were significantly associated with a high odds ratio (P = 0.0027; OR 8.97, 95% CI 1.8–51.9). We conclude that NRXN1 deletions affecting exons confer risk of schizophrenia.

12 July 2007 in BMJ
Verified
Journal Article
Closed access
PDF file
MPMarco M Picchioni
Marco M Picchioni
RMRobin M Murray
Robin M Murray
MethodsWe searched the online electronic databases Web of Knowledge, the Cochrane Library, and the current National Institute for Health and Clinical Excellence (NICE) guidelines for suitable evidence based material.

20 February 2012 in International Journal of Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
CFCatherine Frogley
Catherine Frogley
DTDavid Taylor
David Taylor
GDGeoffrey L. Dickens
Geoffrey L. Dickens
MPMarco Picchioni
Marco Picchioni
Reducing the risk of violent and aggressive behaviour in patients with schizophrenia remains a clinical priority. There is emerging evidence to sugge

9 June 2009 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
MCM C Craig
M C Craig
MCM Catani
M Catani
QDQ Deeley
Q Deeley
RLR Latham
R Latham
EDE Daly
E Daly
DMD G M Murphy
D G M Murphy